Pfizer-biontech
- All
- News
- Videos
-
'Positive' Trial For Pfizer-BioNTech Covid-Flu Jab
"A pivotal phase three trial evaluating these lead formulations is expected to be initiated in the coming months," they said.
-
Pfizer-BioNTech To Test Combined Vaccine For Covid, Flu
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Pfizer-BioNTech Begin Trials For An Omicron-Specific Vaccine
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.
-
Pfizer Vaccine Cuts Omicron Hospitalisation By 70% In South Africa: Study
Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70 per cent protection against hospitalisation in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant.
-
Switzerland Approves Covid Vaccination Of Children Aged Between 5 And 11
The Swiss medicines agency Swissmedic on Friday approved the vaccination of children aged between five and 11 with Pfizer-Biontech's Comirnaty vaccine.
-
US Authorizes Pfizer Covid Booster For People Aged 16 And 17
The US Food and Drug Administration (FDA) on Thursday expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds.
-
UK Orders 114 Million Additional Covid Jabs Amid 'Omicron' Variant Scare
The UK government said late Wednesday it has ordered 114 million additional Covid-19 vaccine doses, from pharmaceutical giants Pfizer-BioNTech and Moderna, to bolster its jabs drive over the next two years.
-
Iraq Gets 1.2 Million Pfizer Covid Vaccine Doses Amid Fears Of 4th Wave
Iraq said Saturday it has received 1.2 million doses of Pfizer-BioNTech's COVID-19 vaccine through the Covax sharing scheme, amid fears of a fourth wave in the country.
-
Canada Approves Pfizer Covid Vaccine For Children In 5-11 Age Group
Canada on Friday became the latest country to authorize the Pfizer-BioNTech Covid-19 vaccine for children aged between five and 11-years-old, according to an official statement.
-
"Turning Point": Joe Biden On US' Pfizer Vaccine Approval For 5 To 11 Year Olds
The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine, US health authorities said Tuesday as they gave final approval to this new phase of fighting the pandemic.
-
Pfizer Seeks Approval For Covid Jabs For Children Aged 5-11 In Canada
Pfizer-BioNTech submitted an authorization request to Health Canada on Monday for the use of its Covid-19 vaccine in children aged 5-11, the companies and the Canadian government said.
-
US To Donate 500 Million More Covid Vaccines To Other Countries: Biden
President Joe Biden will announce Wednesday the US plans to donate an additional 500 million Pfizer-BioNTech Covid vaccines to the rest of the world, bringing its total commitment to 1.1 billion, officials said.
-
New Zealand's Auckland To Stay In Lockdown For 2 More Weeks
New Zealand Prime Minister Jacinda Ardern on Monday extended a lockdown in Auckland by two weeks, while officials reported the country's first death linked to the Pfizer-BioNTech COVID-19 vaccine.
-
'Positive' Trial For Pfizer-BioNTech Covid-Flu Jab
"A pivotal phase three trial evaluating these lead formulations is expected to be initiated in the coming months," they said.
-
Pfizer-BioNTech To Test Combined Vaccine For Covid, Flu
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Pfizer-BioNTech Begin Trials For An Omicron-Specific Vaccine
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.
-
Pfizer Vaccine Cuts Omicron Hospitalisation By 70% In South Africa: Study
Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70 per cent protection against hospitalisation in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant.
-
Switzerland Approves Covid Vaccination Of Children Aged Between 5 And 11
The Swiss medicines agency Swissmedic on Friday approved the vaccination of children aged between five and 11 with Pfizer-Biontech's Comirnaty vaccine.
-
US Authorizes Pfizer Covid Booster For People Aged 16 And 17
The US Food and Drug Administration (FDA) on Thursday expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds.
-
UK Orders 114 Million Additional Covid Jabs Amid 'Omicron' Variant Scare
The UK government said late Wednesday it has ordered 114 million additional Covid-19 vaccine doses, from pharmaceutical giants Pfizer-BioNTech and Moderna, to bolster its jabs drive over the next two years.
-
Iraq Gets 1.2 Million Pfizer Covid Vaccine Doses Amid Fears Of 4th Wave
Iraq said Saturday it has received 1.2 million doses of Pfizer-BioNTech's COVID-19 vaccine through the Covax sharing scheme, amid fears of a fourth wave in the country.
-
Canada Approves Pfizer Covid Vaccine For Children In 5-11 Age Group
Canada on Friday became the latest country to authorize the Pfizer-BioNTech Covid-19 vaccine for children aged between five and 11-years-old, according to an official statement.
-
"Turning Point": Joe Biden On US' Pfizer Vaccine Approval For 5 To 11 Year Olds
The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine, US health authorities said Tuesday as they gave final approval to this new phase of fighting the pandemic.
-
Pfizer Seeks Approval For Covid Jabs For Children Aged 5-11 In Canada
Pfizer-BioNTech submitted an authorization request to Health Canada on Monday for the use of its Covid-19 vaccine in children aged 5-11, the companies and the Canadian government said.
-
US To Donate 500 Million More Covid Vaccines To Other Countries: Biden
President Joe Biden will announce Wednesday the US plans to donate an additional 500 million Pfizer-BioNTech Covid vaccines to the rest of the world, bringing its total commitment to 1.1 billion, officials said.
-
New Zealand's Auckland To Stay In Lockdown For 2 More Weeks
New Zealand Prime Minister Jacinda Ardern on Monday extended a lockdown in Auckland by two weeks, while officials reported the country's first death linked to the Pfizer-BioNTech COVID-19 vaccine.
